Netherlands

Netherlands

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
6.3 2017 Survey/reported EMCDDA
National
Download
Value (%) Year Type Source
0.87 (0.70 - 1.04) 2019 Modelled IHME
0.88 (0.71 - 1.05) 2018 Modelled IHME
0.9 (0.72 - 1.07) 2017 Modelled IHME
0.91 (0.75 - 1.08) 2016 Modelled IHME
0.92 (0.77 - 1.09) 2015 Modelled IHME
0.92 (0.76 - 1.08) 2014 Modelled IHME
0.92 (0.76 - 1.08) 2013 Modelled IHME
0.91 (0.75 - 1.08) 2012 Modelled IHME
0.91 (0.75 - 1.08) 2011 Modelled IHME
0.91 (0.73 - 1.08) 2010 Modelled IHME
0.9 (0.74 - 1.07) 2009 Modelled IHME
0.9 (0.74 - 1.06) 2008 Modelled IHME
0.89 (0.74 - 1.05) 2007 Modelled IHME
0.89 (0.73 - 1.05) 2006 Modelled IHME
0.89 (0.73 - 1.05) 2005 Modelled IHME
0.89 (0.74 - 1.05) 2004 Modelled IHME
0.9 (0.75 - 1.06) 2003 Modelled IHME
0.91 (0.76 - 1.08) 2002 Modelled IHME
0.92 (0.77 - 1.09) 2001 Modelled IHME
0.93 (0.77 - 1.10) 2000 Modelled IHME
0.93 (0.77 - 1.10) 1999 Modelled IHME
0.92 (0.76 - 1.09) 1998 Modelled IHME
0.92 (0.76 - 1.09) 1997 Modelled IHME
0.91 (0.76 - 1.08) 1996 Modelled IHME
0.91 (0.75 - 1.09) 1995 Modelled IHME
0.91 (0.76 - 1.08) 1994 Modelled IHME
0.92 (0.75 - 1.09) 1993 Modelled IHME
0.92 (0.76 - 1.09) 1992 Modelled IHME
0.93 (0.77 - 1.11) 1991 Modelled IHME
0.94 (0.77 - 1.13) 1990 Modelled IHME
0.34 (0.22 - 0.47) 2016 Survey/reported Koopsen J et al, 2019
0.2 (0.10 - 0.40) 2007 Survey/reported Hahne SJM et al, 2012
0.09 (0.07 - 0.11) 2015 Modelled WHO
0.3 (0.10 - 0.40) 2016 Modelled Razavi-Shearer et al, 2018
0.2 (0.10 - 0.40) 2007 Survey/reported ECDC
0.4 (0.39 - 0.41) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.07) 2019 Modelled IHME
0.06 (0.04 - 0.08) 2018 Modelled IHME
0.06 (0.04 - 0.08) 2017 Modelled IHME
0.07 (0.05 - 0.09) 2016 Modelled IHME
0.08 (0.06 - 0.11) 2015 Modelled IHME
0.12 (0.08 - 0.16) 2014 Modelled IHME
0.18 (0.12 - 0.24) 2013 Modelled IHME
0.25 (0.17 - 0.34) 2012 Modelled IHME
0.31 (0.21 - 0.43) 2011 Modelled IHME
0.34 (0.22 - 0.47) 2010 Modelled IHME
0.34 (0.23 - 0.46) 2009 Modelled IHME
0.34 (0.23 - 0.46) 2008 Modelled IHME
0.34 (0.23 - 0.45) 2007 Modelled IHME
0.34 (0.23 - 0.45) 2006 Modelled IHME
0.34 (0.23 - 0.44) 2005 Modelled IHME
0.35 (0.24 - 0.46) 2004 Modelled IHME
0.37 (0.25 - 0.49) 2003 Modelled IHME
0.4 (0.27 - 0.52) 2002 Modelled IHME
0.42 (0.28 - 0.55) 2001 Modelled IHME
0.43 (0.28 - 0.56) 2000 Modelled IHME
0.43 (0.28 - 0.56) 1999 Modelled IHME
0.42 (0.27 - 0.56) 1998 Modelled IHME
0.42 (0.27 - 0.56) 1997 Modelled IHME
0.42 (0.27 - 0.56) 1996 Modelled IHME
0.42 (0.27 - 0.55) 1995 Modelled IHME
0.42 (0.27 - 0.55) 1994 Modelled IHME
0.42 (0.27 - 0.55) 1993 Modelled IHME
0.42 (0.27 - 0.55) 1992 Modelled IHME
0.42 (0.28 - 0.56) 1991 Modelled IHME
0.43 (0.29 - 0.58) 1990 Modelled IHME
0.04 (0.03 - 0.05) 2015 Modelled WHO
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
0.48 2017 Survey/reported ECDC Monitoring Report
0.83 2017 Survey/reported ECDC Monitoring Report
0.83 2017 Survey/reported ECDC
0.48 2017 Survey/reported ECDC
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.3 (0.30 - 0.40) 2016 Modelled ECDC
0.3 (0.30 - 0.40) 2006 Survey/reported Op de Coul EL et al, 2011
0.3 (0.30 - 0.40) 2007 Survey/reported Op de Coul EL et al, 2011
0.4 (0.40 - 0.40) 2008 Survey/reported Op de Coul EL et al, 2011
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
139,736 (114,707 - 168,093) 1990 Modelled IHME
139,462 (115,147 - 166,726) 1991 Modelled IHME
139,390 (115,154 - 165,546) 1992 Modelled IHME
139,535 (114,930 - 165,549) 1993 Modelled IHME
139,928 (115,902 - 166,026) 1994 Modelled IHME
140,596 (116,105 - 167,560) 1995 Modelled IHME
141,662 (117,288 - 168,040) 1996 Modelled IHME
143,122 (118,822 - 170,076) 1997 Modelled IHME
144,762 (119,966 - 171,651) 1998 Modelled IHME
146,317 (121,212 - 173,909) 1999 Modelled IHME
147,512 (121,758 - 175,533) 2000 Modelled IHME
147,702 (122,478 - 175,036) 2001 Modelled IHME
146,838 (121,631 - 173,215) 2002 Modelled IHME
145,546 (120,732 - 171,618) 2003 Modelled IHME
144,473 (119,402 - 170,790) 2004 Modelled IHME
144,301 (118,842 - 171,262) 2005 Modelled IHME
145,055 (119,604 - 171,554) 2006 Modelled IHME
146,201 (120,691 - 172,705) 2007 Modelled IHME
147,589 (121,409 - 175,096) 2008 Modelled IHME
149,031 (121,843 - 177,081) 2009 Modelled IHME
150,304 (121,419 - 178,790) 2010 Modelled IHME
151,515 (124,262 - 179,517) 2011 Modelled IHME
152,819 (125,829 - 180,725) 2012 Modelled IHME
154,090 (127,271 - 181,847) 2013 Modelled IHME
155,212 (128,179 - 182,565) 2014 Modelled IHME
156,012 (129,694 - 184,706) 2015 Modelled IHME
155,147 (127,587 - 183,749) 2016 Modelled IHME
153,200 (122,775 - 181,821) 2017 Modelled IHME
151,213 (121,996 - 179,506) 2018 Modelled IHME
148,649 (120,605 - 178,493) 2019 Modelled IHME
47,000 (25,000 - 68,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.65 (1.27 - 2.11) 2019 Modelled IHME
1.64 (1.26 - 2.10) 2018 Modelled IHME
1.64 (1.25 - 2.08) 2017 Modelled IHME
1.62 (1.25 - 2.08) 2016 Modelled IHME
1.58 (1.22 - 2.03) 2015 Modelled IHME
1.56 (1.20 - 1.99) 2014 Modelled IHME
1.58 (1.22 - 2.02) 2013 Modelled IHME
1.61 (1.25 - 2.06) 2012 Modelled IHME
1.61 (1.24 - 2.05) 2011 Modelled IHME
1.62 (1.25 - 2.05) 2010 Modelled IHME
1.61 (1.24 - 2.04) 2009 Modelled IHME
1.61 (1.24 - 2.05) 2008 Modelled IHME
1.6 (1.23 - 2.05) 2007 Modelled IHME
1.61 (1.24 - 2.10) 2006 Modelled IHME
1.63 (1.25 - 2.11) 2005 Modelled IHME
1.67 (1.28 - 2.16) 2004 Modelled IHME
1.74 (1.34 - 2.26) 2003 Modelled IHME
1.68 (1.29 - 2.18) 2002 Modelled IHME
1.63 (1.26 - 2.11) 2001 Modelled IHME
1.6 (1.24 - 2.07) 2000 Modelled IHME
1.57 (1.21 - 2.02) 1999 Modelled IHME
1.52 (1.17 - 1.96) 1998 Modelled IHME
1.49 (1.15 - 1.93) 1997 Modelled IHME
1.48 (1.14 - 1.93) 1996 Modelled IHME
1.46 (1.12 - 1.89) 1995 Modelled IHME
1.42 (1.09 - 1.84) 1994 Modelled IHME
1.4 (1.07 - 1.82) 1993 Modelled IHME
1.35 (1.03 - 1.75) 1992 Modelled IHME
1.32 (1.02 - 1.70) 1991 Modelled IHME
1.29 (0.99 - 1.67) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
283 (218 - 362) 2019 Modelled IHME
281 (216 - 359) 2018 Modelled IHME
279 (213 - 355) 2017 Modelled IHME
276 (212 - 353) 2016 Modelled IHME
268 (206 - 343) 2015 Modelled IHME
262 (202 - 335) 2014 Modelled IHME
265 (205 - 339) 2013 Modelled IHME
270 (208 - 345) 2012 Modelled IHME
268 (206 - 342) 2011 Modelled IHME
268 (207 - 341) 2010 Modelled IHME
267 (205 - 337) 2009 Modelled IHME
265 (204 - 338) 2008 Modelled IHME
262 (201 - 336) 2007 Modelled IHME
264 (203 - 343) 2006 Modelled IHME
266 (204 - 344) 2005 Modelled IHME
272 (208 - 351) 2004 Modelled IHME
282 (216 - 365) 2003 Modelled IHME
271 (207 - 350) 2002 Modelled IHME
261 (201 - 338) 2001 Modelled IHME
254 (197 - 329) 2000 Modelled IHME
247 (191 - 320) 1999 Modelled IHME
239 (183 - 308) 1998 Modelled IHME
233 (180 - 301) 1997 Modelled IHME
229 (176 - 299) 1996 Modelled IHME
225 (173 - 292) 1995 Modelled IHME
218 (167 - 282) 1994 Modelled IHME
213 (164 - 277) 1993 Modelled IHME
204 (157 - 265) 1992 Modelled IHME
198 (153 - 255) 1991 Modelled IHME
193 (148 - 249) 1990 Modelled IHME
484 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
11 (8 - 16) 2019 Modelled IHME
11 (8 - 16) 2018 Modelled IHME
11 (8 - 16) 2017 Modelled IHME
11 (8 - 16) 2016 Modelled IHME
11 (8 - 16) 2015 Modelled IHME
12 (8 - 17) 2014 Modelled IHME
12 (8 - 17) 2013 Modelled IHME
12 (8 - 17) 2012 Modelled IHME
12 (8 - 17) 2011 Modelled IHME
12 (8 - 17) 2010 Modelled IHME
12 (8 - 17) 2009 Modelled IHME
12 (8 - 17) 2008 Modelled IHME
12 (8 - 17) 2007 Modelled IHME
12 (8 - 17) 2006 Modelled IHME
12 (8 - 17) 2005 Modelled IHME
12 (8 - 17) 2004 Modelled IHME
12 (8 - 17) 2003 Modelled IHME
12 (8 - 17) 2002 Modelled IHME
12 (8 - 17) 2001 Modelled IHME
12 (9 - 17) 2000 Modelled IHME
12 (9 - 17) 1999 Modelled IHME
12 (9 - 17) 1998 Modelled IHME
12 (9 - 17) 1997 Modelled IHME
12 (9 - 18) 1996 Modelled IHME
12 (9 - 18) 1995 Modelled IHME
12 (9 - 18) 1994 Modelled IHME
12 (9 - 18) 1993 Modelled IHME
12 (9 - 18) 1992 Modelled IHME
12 (9 - 18) 1991 Modelled IHME
12 (9 - 18) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
92 2018 Survey/reported WHO/UNICEF
92 2017 Survey/reported WHO/UNICEF
93 2016 Survey/reported WHO/UNICEF
94 2015 Survey/reported WHO/UNICEF
94 2014 Survey/reported WHO/UNICEF
51 2013 Survey/reported WHO/UNICEF
20 2012 Survey/reported WHO/UNICEF
20 2011 Survey/reported WHO/UNICEF
92 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
414 (170 - 659) 2014 Survey/reported van Laar M et al, 2014
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.48 (0.40 - 0.59) 2019 Modelled IHME
0.48 (0.39 - 0.58) 2018 Modelled IHME
0.47 (0.39 - 0.58) 2017 Modelled IHME
0.47 (0.38 - 0.57) 2016 Modelled IHME
0.46 (0.38 - 0.56) 2015 Modelled IHME
0.44 (0.36 - 0.53) 2014 Modelled IHME
0.4 (0.32 - 0.48) 2013 Modelled IHME
0.35 (0.29 - 0.42) 2012 Modelled IHME
0.32 (0.26 - 0.38) 2011 Modelled IHME
0.3 (0.25 - 0.36) 2010 Modelled IHME
0.3 (0.25 - 0.36) 2009 Modelled IHME
0.31 (0.25 - 0.37) 2008 Modelled IHME
0.31 (0.26 - 0.37) 2007 Modelled IHME
0.32 (0.27 - 0.38) 2006 Modelled IHME
0.33 (0.28 - 0.39) 2005 Modelled IHME
0.36 (0.30 - 0.43) 2004 Modelled IHME
0.42 (0.34 - 0.50) 2003 Modelled IHME
0.48 (0.39 - 0.58) 2002 Modelled IHME
0.53 (0.42 - 0.65) 2001 Modelled IHME
0.55 (0.44 - 0.68) 2000 Modelled IHME
0.54 (0.43 - 0.66) 1999 Modelled IHME
0.5 (0.41 - 0.62) 1998 Modelled IHME
0.47 (0.38 - 0.57) 1997 Modelled IHME
0.43 (0.35 - 0.53) 1996 Modelled IHME
0.41 (0.34 - 0.51) 1995 Modelled IHME
0.41 (0.33 - 0.50) 1994 Modelled IHME
0.4 (0.33 - 0.49) 1993 Modelled IHME
0.4 (0.33 - 0.49) 1992 Modelled IHME
0.4 (0.32 - 0.49) 1991 Modelled IHME
0.4 (0.32 - 0.49) 1990 Modelled IHME
0.1 (0 - 0.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.08 (0.03 - 0.13) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
85.7 2017 Survey/reported EMCDDA
National
Download
Value (%) Year Type Source
0.16 (0.06 - 0.27) 2019 Survey/reported Koopsen J et al, 2019
0.1 (0 - 0.20) 2007 Survey/reported Vriend HJ et al, 2013
0.2 (0.10 - 0.40) 2014 Survey/reported Gower et al, 2014
0.22 2019 Modelled Jin et al. 2017
0.1 (0 - 0.20) 2007 Survey/reported ECDC
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.3 (0.80 - 1.90) 2003 Survey/reported van de Laar TJ et al , 2007
0.7 (0.10 - 1.90) 2007 Survey/reported Van Rooijen MS et al , 2013
4.8 2017 Survey/reported ECDC
3.7 2019 Modelled Jin et al. 2017
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
8.2 (5.10 - 12.10) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
55.3 (49.70 - 60.90) 2017 Modelled Degenhardt L et al, 2017
39.3 2013 Survey/reported EMCDDA
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
59,046 (48,130 - 72,716) 1990 Modelled IHME
59,576 (48,646 - 73,538) 1991 Modelled IHME
60,320 (49,356 - 74,082) 1992 Modelled IHME
61,249 (50,152 - 75,059) 1993 Modelled IHME
62,336 (51,180 - 76,969) 1994 Modelled IHME
63,555 (51,896 - 78,137) 1995 Modelled IHME
66,740 (54,531 - 81,455) 1996 Modelled IHME
72,571 (58,952 - 88,392) 1997 Modelled IHME
79,242 (64,022 - 96,684) 1998 Modelled IHME
84,879 (68,091 - 103,986) 1999 Modelled IHME
87,559 (69,550 - 107,899) 2000 Modelled IHME
84,715 (67,889 - 103,508) 2001 Modelled IHME
76,988 (62,661 - 93,265) 2002 Modelled IHME
67,293 (55,588 - 80,656) 2003 Modelled IHME
58,614 (48,986 - 69,601) 2004 Modelled IHME
54,004 (45,004 - 64,237) 2005 Modelled IHME
52,551 (43,625 - 62,548) 2006 Modelled IHME
51,347 (42,579 - 61,187) 2007 Modelled IHME
50,470 (41,594 - 60,202) 2008 Modelled IHME
49,985 (40,902 - 59,921) 2009 Modelled IHME
49,950 (40,813 - 60,116) 2010 Modelled IHME
52,655 (42,988 - 63,030) 2011 Modelled IHME
58,946 (48,289 - 70,376) 2012 Modelled IHME
66,694 (54,484 - 79,844) 2013 Modelled IHME
73,746 (60,159 - 88,823) 2014 Modelled IHME
77,889 (63,469 - 94,357) 2015 Modelled IHME
79,472 (65,280 - 96,296) 2016 Modelled IHME
80,656 (66,077 - 98,152) 2017 Modelled IHME
81,738 (67,041 - 99,584) 2018 Modelled IHME
82,650 (67,911 - 101,039) 2019 Modelled IHME
16,000 (5,000 - 26,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
3,000 (940 - 4,600) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.62 (2.86 - 4.43) 2019 Modelled IHME
3.56 (2.81 - 4.36) 2018 Modelled IHME
3.52 (2.76 - 4.31) 2017 Modelled IHME
3.5 (2.80 - 4.29) 2016 Modelled IHME
3.4 (2.69 - 4.19) 2015 Modelled IHME
3.29 (2.59 - 4.05) 2014 Modelled IHME
3.24 (2.58 - 3.99) 2013 Modelled IHME
3.2 (2.57 - 3.95) 2012 Modelled IHME
3.09 (2.46 - 3.81) 2011 Modelled IHME
3.03 (2.40 - 3.72) 2010 Modelled IHME
2.99 (2.38 - 3.67) 2009 Modelled IHME
2.96 (2.37 - 3.63) 2008 Modelled IHME
2.91 (2.33 - 3.58) 2007 Modelled IHME
2.91 (2.30 - 3.59) 2006 Modelled IHME
2.9 (2.29 - 3.60) 2005 Modelled IHME
2.95 (2.33 - 3.66) 2004 Modelled IHME
3.04 (2.41 - 3.77) 2003 Modelled IHME
2.95 (2.33 - 3.65) 2002 Modelled IHME
2.85 (2.27 - 3.56) 2001 Modelled IHME
2.78 (2.21 - 3.50) 2000 Modelled IHME
2.73 (2.17 - 3.39) 1999 Modelled IHME
2.66 (2.12 - 3.29) 1998 Modelled IHME
2.61 (2.09 - 3.22) 1997 Modelled IHME
2.56 (2.05 - 3.17) 1996 Modelled IHME
2.53 (2.01 - 3.14) 1995 Modelled IHME
2.46 (1.95 - 3.05) 1994 Modelled IHME
2.42 (1.92 - 3) 1993 Modelled IHME
2.33 (1.86 - 2.91) 1992 Modelled IHME
2.27 (1.81 - 2.83) 1991 Modelled IHME
2.23 (1.77 - 2.78) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
621 (491 - 760) 2019 Modelled IHME
609 (480 - 746) 2018 Modelled IHME
599 (471 - 734) 2017 Modelled IHME
595 (476 - 728) 2016 Modelled IHME
575 (455 - 708) 2015 Modelled IHME
554 (437 - 683) 2014 Modelled IHME
543 (433 - 670) 2013 Modelled IHME
535 (430 - 661) 2012 Modelled IHME
516 (410 - 635) 2011 Modelled IHME
503 (398 - 618) 2010 Modelled IHME
495 (394 - 607) 2009 Modelled IHME
487 (391 - 598) 2008 Modelled IHME
478 (382 - 587) 2007 Modelled IHME
476 (377 - 587) 2006 Modelled IHME
473 (373 - 587) 2005 Modelled IHME
479 (378 - 594) 2004 Modelled IHME
492 (389 - 609) 2003 Modelled IHME
474 (375 - 586) 2002 Modelled IHME
456 (363 - 569) 2001 Modelled IHME
442 (351 - 556) 2000 Modelled IHME
431 (343 - 536) 1999 Modelled IHME
417 (333 - 516) 1998 Modelled IHME
407 (326 - 502) 1997 Modelled IHME
398 (317 - 492) 1996 Modelled IHME
390 (311 - 484) 1995 Modelled IHME
376 (299 - 467) 1994 Modelled IHME
368 (292 - 457) 1993 Modelled IHME
352 (281 - 441) 1992 Modelled IHME
342 (272 - 426) 1991 Modelled IHME
332 (264 - 415) 1990 Modelled IHME
634 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
35 (27 - 44) 2019 Modelled IHME
35 (26 - 44) 2018 Modelled IHME
35 (26 - 44) 2017 Modelled IHME
35 (26 - 44) 2016 Modelled IHME
35 (26 - 43) 2015 Modelled IHME
35 (26 - 43) 2014 Modelled IHME
34 (26 - 43) 2013 Modelled IHME
34 (26 - 43) 2012 Modelled IHME
34 (26 - 43) 2011 Modelled IHME
34 (26 - 42) 2010 Modelled IHME
34 (26 - 42) 2009 Modelled IHME
34 (26 - 42) 2008 Modelled IHME
34 (26 - 42) 2007 Modelled IHME
34 (26 - 42) 2006 Modelled IHME
34 (26 - 42) 2005 Modelled IHME
34 (26 - 42) 2004 Modelled IHME
34 (25 - 42) 2003 Modelled IHME
34 (25 - 42) 2002 Modelled IHME
34 (25 - 42) 2001 Modelled IHME
34 (25 - 42) 2000 Modelled IHME
34 (25 - 42) 1999 Modelled IHME
34 (26 - 42) 1998 Modelled IHME
34 (26 - 42) 1997 Modelled IHME
34 (26 - 42) 1996 Modelled IHME
34 (25 - 42) 1995 Modelled IHME
34 (26 - 42) 1994 Modelled IHME
34 (25 - 43) 1993 Modelled IHME
34 (25 - 43) 1992 Modelled IHME
34 (26 - 43) 1991 Modelled IHME
34 (25 - 43) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
414 (170 - 659) 2014 Survey/reported van Laar M et al, 2014
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.87 (%)
2019
(0.7 - 1.04(%))
IHME
HCV (RNA/cAg+)
0.48 (%)
2019
(0.4 - 0.59(%))
IHME

Survey/surveillance

HBV (HBsAg+)
0.34 (%)
2016
(0.22 - 0.47(%))
Koopsen J et al, 2019
HCV (anti-HCV)
0.16 (%)
2019
(0.06 - 0.27(%))
Koopsen J et al, 2019

Hepatitis related deaths (national)

Modelled

HBV
283
2019
(218 - 362)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
621
2019
(491 - 760)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.06 (%)
2019, latest modelled
(0.04 - 0.07(%))
IHME

Prevalence PWID

HCV
39.30 (%)
2013, survey/surveillance
EMCDDA

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
414
2014
(170 - 659)
van Laar M et al, 2014
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

Action plan

View all

News

Action plans

Resources